fda approval of crysvita® for x-linked hypophosphatemia (xlh)
Published 6 years ago • 2.4K plays • Length 7:05Download video MP4
Download video MP3
Similar videos
-
8:27
x-linked hypophosphatemia (xlh) patient on fda approval of crysvita® (april 2018)
-
12:49
fda approval (april 2018) of crysvita® for the treatment xlh
-
4:15
x linked hypophosphatemia xlh
-
1:26:18
webinar: crysvita question & answer session
-
8:08
x-linked hypophosphatemia
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
8:01
fda d.i.s.c.o.: fda approval of cablivi for acquired thrombotic thrombocytopenic purpura
-
9:15
fda approval of lynparza® in us for hrr gene-mutated mcrpc
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
0:45
fda approval of teclistamab for r/r multiple myeloma and the value of immunotherapies
-
6:31
fda d.i.s.c.o. burst edition: fda approvals of lumakras (sotorasib) for patients with kras g12c ...
-
2:59
dr. david spigel & fda approval of vitrakvi, drug targeted to genetic mutation, not cancer
-
2:19
design of a phase i trial of eftozanermin alfa plus bortezomib and dex in r/r myeloma
-
2:20
avapritinib fda approval for advanced systemic mastocytosis
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
1:25
recent fda approval of exa-cel & lovo-cel for patients with scd
-
1:36
a look at the expansion of a biosimilar’s fda label with sue naeyaert
-
1:55
dr. hurvitz on the fda approval process for biosimilars
-
1:43
the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b